Skip to main content

Published locations for FDA approves enasidenib to treat relapsed/refractory AML

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves enasidenib to treat relapsed/refractory AML

User login

  • Reset your password
  • /content/fda-approves-enasidenib-treat-relapsed/refractory-aml
  • /hematology-oncology/article/185526/leukemia-myelodysplasia-transplantation/fda-approves-enasidenib-treat
  • /hematologytimes/article/185526/leukemia-myelodysplasia-transplantation/fda-approves-enasidenib-treat